Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002452 | A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir | PHASE2 | COMPLETED | 30 | — | — | - | - | Jun 24, 2005 | 8 | United States |
| Name | Type | Description |
|---|---|---|
| L-756423 | DRUG | - |
| Indinavir sulfate | DRUG | - |
Inclusion Criteria You may be eligible for this study if you: * Are HIV-positive. * Are at least 18 years old. * Have a viral load of at least 1,000 copies/ml. * Have a CD4 cell count of at least 100 cells/mm3. * Have experienced treatment failure (your viral load increased significantly) within 2...